Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CapsoVision, Inc Director's Dealing 2025

Jul 2, 2025

33655_dirs_2025-07-01_0d81a99c-2395-487e-a82b-1760700a9469.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CapsoVision, Inc (CV)
CIK: 0001378325
Period of Report: 2025-07-01

Reporting Person: Wang Kang-Huai (N/A)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 915207 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series A Preferred Stock $ Common Stock (1407407) Direct
Series C-1 Preferred Stock $ Common Stock (33707) Direct
Series D Preferred Stock $ Common Stock (11111) Direct
Series H Preferred Stock $ Common Stock (35947) Direct
Stock Option (right to buy) $0.110 2031-06-14 Common Stock (3334) Direct
Stock Option (right to buy) $0.110 2032-03-22 Common Stock (11459) Direct
Stock Option (right to buy) $0.170 2034-10-23 Common Stock (887500) Direct

Footnotes

F1: Does not reflect a one-for-3.33 reverse stock split, to be effective immediately prior to the closing to the Issuer's initial public offering.

F2: Each share of Series A preferred stock, Series C-1 preferred stock, Series D preferred stock and Series H preferred stock (the "Preferred Stock") is convertible on a one-to-one basis into the underlying shares of common stock at the holder's election and has no expiration date. The Preferred Stock will automatically convert into common stock upon the closing of the Issuer's initial public offering. The number of underlying shares of common stock reported in Column 3 does not reflect a one-for-3.33 reverse stock split, to be effective immediately prior to the closing to the Issuer's initial public offering.

F3: The derivative security is fully vested as to the original number of underlying shares of common stock, which was 80,000 shares. Prior to July 1, 2025, the reporting person partially exercised the stock option and purchased 76,666 of the underlying shares which had vested.

F4: The number of underlying shares of common stock reported in Column 3 and the exercise price reported in Column 4 do not reflect a one-for-3.33 reverse stock split, to be effective immediately prior to the closing to the Issuer's initial public offering.

F5: The options vested as to 25% of the original number of underlying shares of common stock, which was 50,000 shares, on April 1, 2023 and as to the remaining 75% of the shares in 36 equal monthly installments thereafter through April 1, 2026, subject to continued service to the Issuer on each such date. The options, to the extent then outstanding and unvested, will vest in full upon a change in control of the Issuer. Prior to July 1, 2025, the reporting person partially exercised the stock option and purchased 38,541 of the underlying shares which had vested.

F6: The options vest as to 25% of the shares on November 1, 2025 and as to the remaining 75% of the shares in 36 equal monthly installments thereafter through November 1, 2028, subject to continued service to the Issuer on each such date. The options, to the extent then outstanding and unvested, will vest in full upon a change in control of the Issuer.